Immunosuppressive activities of recombinant glycosylation - Inhibiting factor mutants

Journal of Immunology

Volumn 162, Issue 1, 1999, Pages 195-202

  Tomura, Takafumi ^a   Watarai, Hiroshi ^a   Honma, Nakayuki ^a   Sato, Masahiro ^a   Iwamatsu, Akihiro ^a   Kato, Yoichi ^a   Kuroki, Ryota ^a   Nakano, Tatsumi ^b   Mikayama, Toshifumi ^a   Ishizaka, Kimishige ^a,b  

^a KIRIN BREWERY CO LTD   (Japan)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLYCOSYLATION INHIBITING FACTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOREGULATION; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; SUPPRESSOR CELL;

ANIMALS; CELL LINE; FEMALE; GLYCOSYLATION; HUMANS; LYMPHOKINES; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; PROSTATIC SECRETORY PROTEINS; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; SUPPRESSOR FACTORS, IMMUNOLOGIC; T-LYMPHOCYTES, REGULATORY;

EID: 0032933557     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ishizaka, K. 1984. Regulation of IgE synthesis. Annu. Rev. Immunol. 2:159.
2. Jardieu, P., T. Uede, and K. Ishizaka. 1984. IgE-binding factors from mouse T lymphocytes. III. Role of antigen-specific suppressor T cells in the formation of IgE-suppressive factor. J. Immunol. 133:3266.
3. Akasaki, M., P. Jardieu, and K. Ishizaka. 1986. Immunosuppressive effects of glycosylation inhibiting factor on the IgE and IgG response. J. Immunol. 136: 3172.
4. Nakano, T., Y. Ishii, and K. Ishizaka. 1996. Biochemical characterization of antigen-specific glycosylation-inhibiting factor from antigen-specific suppressor T cells. I. Identification of a 55-kilodalton glycosylation-inhibiting factor peptide with TCR α-chain determinant. J. Immunol. 156:1728.
5. Ishii, Y., T. Nakano, and K. Ishizaka. 1996. Biochemical characterization of antigen-specific glycosylation-inhibiting factor from antigen-specific suppressor T cells. II. The 55-kDa glycosylation-inhibiting factor peptide is a derivative of TCR α-chain and a subunit of antigen-specific glycosylation-inhibiting factor. J. Immunol. 156:1735.
6. Mikayama, T., T. Nakano, H. Gomi, Y. Nakagawa, Y. C. Liu, M. Sato, A. Iwamatsu, Y. Ishii, W. Y. Weiser, and K. Ishizaka. 1993. Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor. Proc. Natl. Acad. Sci. USA 90:10056.
7. Liu, Y.-C., T. Nakano, C. Elly, and K. Ishizaka. 1994. Requirement of posttranslational modifications for the generation of biologic activity of glycosylation-inhibiting factor. Proc. Natl. Acad. Sci. USA 91:11227.
8. Nakano, T., H. Watarai, Y. C. Liu, Y. Oyama, T. Mikayama, and K. Ishizaka. 1997. Conversion of inactive glycosylation inhibiting factor to bioactive derivatives by modification of a SH group. Proc. Natl. Acad. Sci. USA 94:202.
9. Frankel, A. D., D. S. Bredt, and C. O. Pabo. 1988. Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science 240:70.
10. Green, S., and P. Chambon. 1987. Oestradiol induction of a glucocorticoid-responsive gene by a chimeric receptor. Nature 325:75.
11. Iwata, M., M. Adachi, and K. Ishizaka. 1988. Antigen-specific T cells that form IgE-potentiating factor. IgG-potentiating factor and antigen-specific glycosylation enhancing factor on antigen stimulation. J. Immunol. 140:2534.
12. Jardieu, P., M. Akasaki, and K. Ishizaka. 1987. Carrier-specific suppression of antibody responses by antigen-specific glycosylation inhibiting factor. J. Immunol. 138:1494.
13. Shimonkevitz, R., J. Kappler, P. Marrach, and H. Grey. 1981. Antigen recognition by H-2 restricted T cells. I. Cell-free antigen processing. J. Exp. Med. 158: 303.
14. Takatsu, K., and K. Ishizaka. 1975. Reaginic antibody formation in the mouse. IV. Suppression of IgE and IgG antibody responses to ovalbumin following the administration of high dose urea-denatured antigen. Cell. Immunol. 20:276.
15. Liu, F. T., J. W. Bohn, E. L. Ferry, H. Yamamoto, C. A. Molinaro, L. A. Sherman, N. R. Klinman, and D. H. Katz. 1980. Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J. Immunol. 124:2728.
16. Vander-Mallie, R., T. Ishizaka, and K. Ishizaka. 1982. Lymphocytes bearing Fc receptors for IgE VIII: affinity of mouse IgE for FcR on mouse B lymphocytes. J. Immunol. 128:2306.
17. Hirano, T., H. Miyajima, H. Kitagawa, N. Watanabe, M. Azuma, O. Taniguchi, H. Hashimoto, S. Hirose, H. Yagita, S. Furusawa, Z. Ovary, and K. Okumura. 1988. Studies on murine IgE with monoclonal antibodies. I. Characterization of rat monoclonal anti-IgE antibodies and the use of these antibodies for determinations of serum IgE levels and for anaphylactic reactions. Int. Arch. Allergy Appl. Immunol. 85:47.
18. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
19. Nakano, T., Y. C. Liu, T. Mikayama, H. Watarai, M. Taniguchi, and K. Ishizaka. 1995. Association of the "major histocompatibility complex subregion" I-J determinant with bioactive glycosylation-inhibiting factor. Proc. Natl. Acad. Sci. USA 92:9196.
20. Iwata, M., and K. Ishizaka. 1988. Construction of antigen-specific suppressor T cell hybridomas from spleen cells of mice primed for the persistent IgE antibody formation. J. Immunol. 141:3270.
21. Paralkar, V., and G. Wistow. 1994. Cloning the human gene for macrophage migration inhibitory factor (MIF). Genomics 19:48.
22. Kim, P. S., and R. L. Balswin. 1990. Intermediates in the folding reactions of small proteins. Annu. Rev. Biochem. 59:631.
23. Kato, Y., T. Muto, T. Tomura, H. Tsumura, H. Watarai, T. Mikayama, K. Ishizaka, and R. Kuroki. 1996. The crystal structure of human glycosylation inhibiting factor is a trimmer barrel with three 6-stranded β-sheets. Proc. Natl. Acad. Sci. USA 93:3007.
24. Kraulis, P. J. 1991. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:946.
25. Dörmann, P., T. Börchers, U. Korf, P. Højrup, P. Roepstorff, and F. Spener. 1993. Amino acid exchange and covalent modification by cysteme and glutathione explain isoforms of fatty acid-binding protein occurring in bovine liver. J. Biol. Chem. 268:16286.
26. Tagaya, Y., A. Mori, and K. Ishizaka. 1991. Biochemical characterization of murine glycosylation-inhibiting factor. Proc. Natl. Acad. Sci. USA 88:9117.
27. Thomas, P., H. Gomi, T. Takeuchi, C. Carini, Y. Tagaya, and K. Ishizaka. 1992. Glycosylation-inhibiting factor from human T cell hybridomas constructed from peripheral blood lymphocytes of a bee venom-sensitive allergic patient. J. Immunol. 148:729.
28. Sugie, K., T. Nakano, T. Tomura, K. Takakura, T. Mikayama, and K. Ishizaka. 1997. High-affinity binding of bioactive glycosylation-inhibiting factor to antigen-primed T cells and natural killer cells. Proc. Natl. Acad. Sci. USA 94:5278.
29. Weiser, W. Y., P. A. Temple, J. S. Witek-Gianotti, H. G. Remold, S. C. Clark, and J. R. David. 1989. Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc. Natl. Acad. Sci. USA 86:7522.
30. Herriott, M. J., H. Jiang, C. A. Stewart, D. J. Fast, and R. W. Leu. 1993. Mechanistic differences between migration inhibitory factor (MIF) and IFN-γ synergize with lipid A to mediate migration inhibition but only IFN-γ induces production of TNF-α and nitric oxide. J. Immunol. 150:4524.
31. Bernhagen, J., R. A. Mitchell, T. Calandra, W. Voelter, A. Cerami, and R. Bucala. 1994. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33:14144.
32. Calandra, T., J. Bernhagen, R. A. Mitchell, and R. Bucala. 1994. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179:1895.
33. Ishii, Y., T. Nakano, and K. Ishizaka. 1996. Cellular mechanisms for the formation of a soluble form derivative of T-cell receptor α chain by suppressor T cells. Proc. Natl. Acad. Sci. USA 93:7207.